Calculated haemorheological profile and laboratory parameters in new diagnosed multiple myeloma patients: retrospective analysis according to survival
Melania Carlisi, Rosalia Lo Presti, Corinne Spoto, Salvatrice Mancuso, Sergio Siragusa, Gregorio Caimi · 2024
Read Calculated haemorheological profile and laboratory parameters in new diagnosed multiple myeloma patients: retrospective analysis according to survival by Melania Carlisi, Rosalia Lo Presti, Corinne Spoto, Salvatrice Mancuso, Sergio Siragusa, Gregorio Caimi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11585042.txt.
Description
Melania Carlisi, Rosalia Lo Presti, Corinne Spoto, Salvatrice Mancuso, Sergio Siragusa, and Gregorio Caimi sort lab values by survival in multiple myeloma in this 2024 study. Myeloma is a cancer of plasma cells with a tangled clinical picture, and doctors need cheap, quick ways to judge outlook.
The Palermo team reviewed 190 newly diagnosed patients seen between 2017 and 2022, and about forty percent died during follow-up. Those who died were older and showed wider spread in red cell sizes, plus lower blood protein, albumin, and hemoglobin. Their calculated blood thickness also ran lower. The authors offer these simple measures, some derived from how blood flows, as starting points for sharper prognostic studies.
Catalog record
| CREATOR | Melania Carlisi, Rosalia Lo Presti, Corinne Spoto, Salvatrice Mancuso, Sergio Siragusa, Gregorio Caimi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |